| Literature DB >> 21116722 |
Kaori Suto1, Ken Urabe, Kouji Naruse, Kentaro Uchida, Terumasa Matsuura, Yuko Mikuni-Takagaki, Mitsutoshi Suto, Noriko Nemoto, Kentaro Kamiya, Moritoshi Itoman.
Abstract
Frozen bone-patellar tendon bone allografts are useful in anterior cruciate ligament reconstruction as the freezing procedure kills tissue cells, thereby reducing immunogenicity of the grafts. However, a small portion of cells in human femoral heads treated by standard bone-bank freezing procedures survive, thus limiting the effectiveness of allografts. Here, we characterized the survival rates and mechanisms of cells isolated from rat bones and tendons that were subjected to freeze-thaw treatments, and evaluated the influence of these treatments on the mechanical properties of tendons. After a single freeze-thaw cycle, most cells isolated from frozen bone appeared morphologically as osteocytes and expressed both osteoblast- and osteocyte-related genes. Transmission electron microscopic observation of frozen cells using freeze-substitution revealed that a small number of osteocytes maintained large nuclei with intact double membranes, indicating that these osteocytes in bone matrix were resistant to ice crystal formation. We found that tendon cells were completely killed by a single freeze-thaw cycle, whereas bone cells exhibited a relatively high survival rate, although survival was significantly reduced after three freeze-thaw cycles. In patella tendons, the ultimate stress, Young's modulus, and strain at failure showed no significant differences between untreated tendons and those subjected to five freeze-thaw cycles. In conclusion, we identified that cells surviving after freeze-thaw treatment of rat bones were predominantly osteocytes. We propose that repeated freeze-thaw cycles could be applied for processing bone-tendon constructs prior to grafting as the treatment did not affect the mechanical property of tendons and drastically reduced surviving osteocytes, thereby potentially decreasing allograft immunogenecity.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21116722 PMCID: PMC3286509 DOI: 10.1007/s10561-010-9234-0
Source DB: PubMed Journal: Cell Tissue Bank ISSN: 1389-9333 Impact factor: 1.522
Primer pairs used for PCR amplification
| Target gene | Accession no.a | Primer pair sequences (sense/antisense)b | Base pairs | Cycles |
|---|---|---|---|---|
| OCN | X04141 | 5′-TGAGGACCCTCTCTCTGCTC-3′ | 127 | 30 |
| 5′-ACCTTACTGCCCTCCTGCTT-3′ | ||||
| SOST | AF326741 | 5′-CAGCTCTCACTAGCCCCTTG-3′ | 228 | 30 |
| 5′-CTCGGACACGTCTTTGGTGT-3′ | ||||
| DMP-1 | NM_203493 | 5′-AGTTCGATGATGAGGGGATG-3′ | 299 | 30 |
| 5′-AGTCTCGCTCCTGCTTTCCT-3′ |
OCN Osteocalcin, SOST sclerostin, DMP-1 dentin matrix protein-1
aGenbank accession number of the sequences used in designing the primers
bPrimer sequences were designed using BLUEPHIN software (Sigma Genosys, Japan)
Fig. 1Cell morphology of cells isolated from rat femoral and tibial bones. Phase-contrast microscopic images of isolated bone cells from two freeze–thaw (FT) treatment groups. a Osteoblastic cells in FT0, b osteocytic cells in FT0, c osteocytic cells in FT1. d Osteocytic cells in FT3. The scale bars indicate 100 μm
Fig. 2Expression of osteoblast- and osteocyte-related marker genes. RT–PCR was used to analyze the expression of the indicated cell-marker genes in bone cells isolated in fraction (Fr) 5–7 from the freeze–thaw (FT) groups FT0 and FT1. GAPDH, glyceraldehydes-3-phosphate dehydrogenase; ALP alkaline phosphatase, PTHr parathyroid hormone receptor, COL1 alpha-1 type I collagen, OCN osteocalcin, SOST sclerostin, and DMP-1 dentin matrix protein 1
Fig. 3Transmission electron microscopic images of bone cells in fresh and frozen states. a Osteoblastic cell in a fresh state. b Osteoblastic cell in a frozen state. c Osteocytic cell in a fresh state. d–f Osteocytic cells in a frozen state. The scale bars indicates 1 μm
Effect of freeze-thaw cycle number on cell survival rate in bone
| Fr 1 | Fr 2 | Fr 3 | Fr 4 | Fr 5 | Fr 6 | Fr 7 | |
|---|---|---|---|---|---|---|---|
| FT0 | 8/8 | 8/8 | 8/8 | 8/8 | 8/8 | 8/8 | 8/8 |
| FT1 | 2/8* | 8/8 | 8/8 | 8/8 | 8/8 | 8/8 | 8/8 |
| FT2 | 0/8* | 2/8* | 3/8 | 3/8 | 3/8 | 4/8 | 3/8 |
| FT3 | 0/8* | 0/8* | 0/8* | 1/8* | 1/8* | 2/8* | 2/8* |
FT Freeze–thaw, Fr fraction
*Nominal significance level for FT0 (P < 0.008)
Effect of a single freeze–thaw cycle on cell survival rate in tendons
| Group | Incubation time (h) | ||
|---|---|---|---|
| 4 | 8 | 18 | |
| FT0 | 5/5 | 5/5 | 5/5 |
| FT1 | 0 | 0 | 0 |
FT Freeze–thaw
Mechanical properties of tendons subjected to freeze–thaw treatment
| Group | Number of samples | Ultimate stress (MPa) | Young’s modulus (MPa) | Strain at failure (%) |
|---|---|---|---|---|
| FT0 | 8 | 42.6 ± 16.3 | 206.8 ± 99.2 | 22.0 ± 4.8 |
| FT1 | 8 | 30.7 ± 17.8 | 185.0 ± 119.4 | 17.4 ± 4.1 |
| FT5 | 8 | 46.1 ± 17.9 | 211.4 ± 108.3 | 23.8 ± 4.9 |
FT freeze thaw
All values are presented as the mean ± SD